Celestica Inc. extends its AI-fueled rally as strong chip demand and analyst upgrades drive stocks have been trading up by 13.03 percent
Key Takeaways
- Q3 revenue jumped 83% year over year to $5.83B, beating the $5.46B consensus, while adjusted EPS surged 109% to $3.30 and margin hit a record 8.5%.
- The company sharply lifted its 2026 outlook to $21B revenue and $11.55 adjusted EPS, ahead of Street models, while trimming free cash flow plans to fund heavier growth spending.
- Management unveiled an aggressive 2027 goal for roughly $40B revenue, a 9% adjusted operating margin, and $21.50 adjusted EPS, tied to hyperscaler and frontier AI lab demand.
- Q4 guidance calls for $6.28B–$6.58B revenue and $3.37–$3.57 adjusted EPS with an 8.7% margin, pointing to continued strong near‑term profitability.
- A recent $3.45B equity raise supports $1.5B–$2B in AI‑focused capex, while a planned new buyback signals confidence despite near‑term free cash flow pressure.
Live Update At 12:32:44 EDT: On Tuesday, October 27, 2026 Celestica Inc. stock [NYSE: CLS] is trending up by 13.03%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
CLS has been trading like a high‑beta AI infrastructure proxy, and the numbers back it up. On 2026/10/27, Celestica stock closed near $278.80 after an intraday run from $264.31 to $283. That bounce came right after a heavy slide from above $380 earlier in the month, so traders are dealing with a name that already ran hard, pulled back, and is now trying to reset.
Under the hood, CLS is posting serious scale. Trailing revenue is about $12.39B with revenue growth north of 20% annually over the last five years. An EBIT margin near 8.8% and gross margin around 12% show this is not a razor‑thin contract manufacturer anymore; the mix is improving. Return on equity above 50% and strong return on capital tell traders management is squeezing real profit from every dollar deployed.
More Breaking News
- Datavault AI Falls 30% After WiSA Patent News
- AIOK Stock Erupts As $18M Asset Sale Ignites Speculation
- CLRO Stock Rockets On Massive Volume As Traders Pile In
- Millrose Properties Rises 2% After Earnings and Raised Outlook
Balance sheet strength matters for a capex cycle, and Celestica’s debt metrics look manageable. Total debt to equity sits around 0.33, with interest coverage near 25 times, giving CLS room to borrow or ride out shocks. A price‑to‑sales ratio near 2.75 and rich price‑to‑book multiple highlight how much future AI growth is already priced in. For active traders, that combination—fast growth, fat returns, and a stretched chart—usually means big swings in both directions.
Why Traders Are Watching CLS Now
Celestica just dropped one of the boldest playbooks in the AI hardware supply chain, and traders are paying attention. CLS is guiding 2027 revenue to roughly $40B, nearly 90% above current levels, with a targeted 9% adjusted operating margin and $21.50 in adjusted EPS. Management is basically telling the market: the hyperscaler and frontier AI lab build‑out is real, it’s big, and Celestica plans to grab a huge slice.
This long‑term story is not coming out of thin air. In Q3 2026, CLS delivered revenue of $5.83B, up 83% year over year, and pushed adjusted EPS up 109% to $3.30. A record 8.5% adjusted operating margin shows Celestica is already scaling profitably, not just chasing volume. For traders, that kind of beat versus the $5.46B revenue consensus is fuel for breakouts, short squeezes, and big after‑hours gaps.
The near‑term setup is also strong. For Q4, Celestica sees $6.28B–$6.58B in revenue and adjusted EPS of $3.37–$3.57, implying another quarter of elevated margins around 8.7%. On top of that, CLS raised its 2026 outlook to $21B revenue and $11.55 adjusted EPS, ahead of prior Street views. That usually forces analysts to chase their models higher, which can keep the trend intact if price action cooperates.
There is a twist. Celestica is sacrificing near‑term free cash flow by leaning into $1.5B–$2B of capex for AI infrastructure, funded in part by a $3.45B equity raise. At the same time, management is talking about a new normal course issuer bid buyback. To active traders, that combination screams conviction: raise cash to build, then use excess strength to retire shares when the market misprices CLS. It is a classic high‑growth, high‑expectation story—great when momentum runs, brutal if execution slips.
Conclusion
For traders who thrive on volatility and story‑driven names, CLS now sits squarely on the AI leaderboard. Celestica has real numbers—83% revenue growth, 109% EPS growth, and expanding margins—backing an aggressive 2026 and 2027 roadmap. The stock’s slide from the $380s to the high‑$200s, followed by a sharp bounce, shows how emotional this tape already is. CLS has gone from quiet contract manufacturer to front‑line AI infrastructure play in a short window.
The key tension is clear. Celestica is pouring cash into capacity just as it promises massive earnings expansion. If hyperscaler and AI lab demand holds, those 2027 targets can keep traders anchored to a bullish script. If the cycle stumbles, the same leverage and rich multiples can snap back hard. That is exactly why disciplined chart reading, risk control, and fast decision‑making matter with CLS. As Tim Bohen, lead trainer with StocksToTrade says, “Time and experience have taught me that missed opportunities are part of the game. There’s always another setup around the corner.” That mindset helps traders avoid forcing entries on CLS when the price action or risk profile is not ideal, and instead wait patiently for cleaner setups that align with their trading rules.
As Tim Sykes likes to remind his trading community, “The market rewards preparation, not prediction—study the pattern, control your risk, and let the price action prove you right.” For anyone tracking Celestica right now, that means watching how CLS trades around guidance updates, AI headlines, and any pullbacks toward support. The opportunity is big, but so is the need for a well‑defined trading plan. This analysis is for educational and research purposes only, and every trader must decide how, or if, CLS fits their own strategy.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.